Mark Lew

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia

Mitchell F. Brin, Mark Lew, Charles H. Adler et al. · Neurology · 1999 · 445 citations

Medicine, Neurology, Rehabilitation Medicine +16

A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease

M. Flint Beal, David Oakes, Ira Shoulson et al. · JAMA Neurology · 2014 · 395 citations · Full text

Medicine, Neurology, Pharmacology +17

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–responsive cervical dystonia

Allison Brashear, Mark Lew, D.D. Dykstra et al. · Neurology · 1999 · 301 citations

Medicine, Neurology, Neurologic Pharmacotherapy +14

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled study

Daniel Truong, Drake D. Duane, Joseph Jankovic et al. · Movement Disorders · 2005 · 243 citations

Medicine, Neurology, Cervical Disease +12

Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia

Mark Lew, Bruce T. Adornato, Drake D. Duane et al. · Neurology · 1997 · 241 citations

Medicine, Neurology, Pharmacotherapy +14